| AZACITIDINE | Small molecule | non-Hodgkins lymphoma | DNA (cytosine-5)-methyltransferase 1 inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
| AZACITIDINE | Small molecule | breast cancer | DNA (cytosine-5)-methyltransferase 1 inhibitor | 2.0 | Recruiting | ClinicalTrials |
| DECITABINE | Small molecule | myelodysplastic syndrome | DNA (cytosine-5)-methyltransferase 1 inhibitor | 2.0 | Recruiting | ClinicalTrials |
| DECITABINE | Small molecule | therapy related acute myeloid leukemia and myelodysplastic syndrome | DNA (cytosine-5)-methyltransferase 1 inhibitor | 2.0 | Completed | ClinicalTrials |
| AZACITIDINE | Small molecule | adult acute myeloid leukemia | DNA (cytosine-5)-methyltransferase 1 inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
| DECITABINE | Small molecule | acute myeloid leukemia | DNA (cytosine-5)-methyltransferase 1 inhibitor | 1.0 | Terminated | ClinicalTrials |
| DECITABINE | Small molecule | acute myeloid leukemia | DNA (cytosine-5)-methyltransferase 1 inhibitor | 2.0 | Recruiting | ClinicalTrials |
| AZACITIDINE | Small molecule | acute myeloid leukemia | DNA (cytosine-5)-methyltransferase 1 inhibitor | 1.0 | Recruiting | ClinicalTrials |
| AZACITIDINE | Small molecule | myeloproliferative disorder | DNA (cytosine-5)-methyltransferase 1 inhibitor | 2.0 | Enrolling by invitation | ClinicalTrials |
| AZACITIDINE | Small molecule | central nervous system cancer | DNA (cytosine-5)-methyltransferase 1 inhibitor | 2.0 | Recruiting | ClinicalTrials |
| AZACITIDINE | Small molecule | neoplasm | DNA (cytosine-5)-methyltransferase 1 inhibitor | 1.0 | Terminated | ClinicalTrials |
| AZACITIDINE | Small molecule | squamous cell carcinoma | DNA (cytosine-5)-methyltransferase 1 inhibitor | 1.0 | Terminated | ClinicalTrials |
| DECITABINE | Small molecule | Mantle cell lymphoma | DNA (cytosine-5)-methyltransferase 1 inhibitor | 1.0 | Completed | ClinicalTrials |
| DECITABINE | Small molecule | precursor T-cell lymphoblastic leukemia-lymphoma | DNA (cytosine-5)-methyltransferase 1 inhibitor | 1.0 | Terminated | ClinicalTrials |
| DECITABINE | Small molecule | lymphoid neoplasm | DNA (cytosine-5)-methyltransferase 1 inhibitor | 1.0 | Terminated | ClinicalTrials |
| DECITABINE | Small molecule | ovarian cancer | DNA (cytosine-5)-methyltransferase 1 inhibitor | 1.0 | Completed | ClinicalTrials |
| DECITABINE | Small molecule | mixed phenotype acute leukemia | DNA (cytosine-5)-methyltransferase 1 inhibitor | 1.0 | Completed | ClinicalTrials |
| DECITABINE | Small molecule | therapy related acute myeloid leukemia and myelodysplastic syndrome | DNA (cytosine-5)-methyltransferase 1 inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
| AZACITIDINE | Small molecule | therapy related acute myeloid leukemia and myelodysplastic syndrome | DNA (cytosine-5)-methyltransferase 1 inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
| DECITABINE | Small molecule | acute myeloid leukemia | DNA (cytosine-5)-methyltransferase 1 inhibitor | 2.0 | Terminated | ClinicalTrials |
| DECITABINE | Small molecule | chronic myelogenous leukemia | DNA (cytosine-5)-methyltransferase 1 inhibitor | 2.0 | Recruiting | ClinicalTrials |
| DECITABINE | Small molecule | non-Hodgkins lymphoma | DNA (cytosine-5)-methyltransferase 1 inhibitor | 0.5 | Completed | ClinicalTrials |
| AZACITIDINE | Small molecule | myelodysplastic syndrome | DNA (cytosine-5)-methyltransferase 1 inhibitor | 1.0 | Recruiting | ClinicalTrials |
| AZACITIDINE | Small molecule | ependymoma | DNA (cytosine-5)-methyltransferase 1 inhibitor | 0.5 | Recruiting | ClinicalTrials |
| DECITABINE | Small molecule | myelodysplastic syndrome | DNA (cytosine-5)-methyltransferase 1 inhibitor | 4.0 | Unknown status | ClinicalTrials |
| DECITABINE | Small molecule | acute lymphoblastic leukemia | DNA (cytosine-5)-methyltransferase 1 inhibitor | 1.0 | Completed | ClinicalTrials |
| AZACITIDINE | Small molecule | angioimmunoblastic T-cell lymphoma | DNA (cytosine-5)-methyltransferase 1 inhibitor | 2.0 | Not yet recruiting | ClinicalTrials |
| DECITABINE | Small molecule | lymphoma | DNA (cytosine-5)-methyltransferase 1 inhibitor | 2.0 | Terminated | ClinicalTrials |
| DECITABINE | Small molecule | acute lymphoblastic leukemia | DNA (cytosine-5)-methyltransferase 1 inhibitor | 1.0 | Recruiting | ClinicalTrials |
| AZACITIDINE | Small molecule | acute myeloid leukemia | DNA (cytosine-5)-methyltransferase 1 inhibitor | 2.0 | Completed | ClinicalTrials |
| AZACITIDINE | Small molecule | breast cancer | DNA (cytosine-5)-methyltransferase 1 inhibitor | 1.0 | Completed | ClinicalTrials |
| AZACITIDINE | Small molecule | acute myeloid leukemia | DNA (cytosine-5)-methyltransferase 1 inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
| AZACITIDINE | Small molecule | lymphoid leukemia | DNA (cytosine-5)-methyltransferase 1 inhibitor | 2.0 | Recruiting | ClinicalTrials |
| AZACITIDINE | Small molecule | chronic myelomonocytic leukemia | DNA (cytosine-5)-methyltransferase 1 inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
| AZACITIDINE | Small molecule | non-small cell lung carcinoma | DNA (cytosine-5)-methyltransferase 1 inhibitor | 1.0 | Terminated | ClinicalTrials |
| DECITABINE | Small molecule | myelodysplastic syndrome | DNA (cytosine-5)-methyltransferase 1 inhibitor | 2.0 | Completed | ClinicalTrials |
| AZACITIDINE | Small molecule | multiple myeloma | DNA (cytosine-5)-methyltransferase 1 inhibitor | 2.0 | Terminated | ClinicalTrials |
| AZACITIDINE | Small molecule | pancreatic ductal adenocarcinoma | DNA (cytosine-5)-methyltransferase 1 inhibitor | 1.0 | Recruiting | ClinicalTrials |
| DECITABINE | Small molecule | renal cell carcinoma | DNA (cytosine-5)-methyltransferase 1 inhibitor | 2.0 | Terminated | ClinicalTrials |
| DECITABINE | Small molecule | therapy related acute myeloid leukemia and myelodysplastic syndrome | DNA (cytosine-5)-methyltransferase 1 inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
| AZACITIDINE | Small molecule | leukemia | DNA (cytosine-5)-methyltransferase 1 inhibitor | 2.0 | Completed | ClinicalTrials |
| DECITABINE | Small molecule | leukemia | DNA (cytosine-5)-methyltransferase 1 inhibitor | 2.0 | Terminated | ClinicalTrials |
| DECITABINE | Small molecule | cancer | DNA (cytosine-5)-methyltransferase 1 inhibitor | 1.0 | Completed | ClinicalTrials |
| AZACITIDINE | Small molecule | myelodysplastic syndrome | DNA (cytosine-5)-methyltransferase 1 inhibitor | 1.0 | Completed | ClinicalTrials |
| DECITABINE | Small molecule | refractory anemia with excess blasts | DNA (cytosine-5)-methyltransferase 1 inhibitor | 4.0 | - | DailyMed |
| DECITABINE | Small molecule | Aplastic anemia | DNA (cytosine-5)-methyltransferase 1 inhibitor | 2.0 | Terminated | ClinicalTrials |
| AZACITIDINE | Small molecule | therapy related acute myeloid leukemia and myelodysplastic syndrome | DNA (cytosine-5)-methyltransferase 1 inhibitor | 2.0 | Recruiting | ClinicalTrials |
| AZACITIDINE | Small molecule | lymphoma | DNA (cytosine-5)-methyltransferase 1 inhibitor | 1.0 | Withdrawn | ClinicalTrials |
| AZACITIDINE | Small molecule | T-cell acute lymphoblastic leukemia | DNA (cytosine-5)-methyltransferase 1 inhibitor | 2.0 | Recruiting | ClinicalTrials |
| DECITABINE | Small molecule | non-small cell lung carcinoma | DNA (cytosine-5)-methyltransferase 1 inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
| AZACITIDINE | Small molecule | non-small cell lung carcinoma | DNA (cytosine-5)-methyltransferase 1 inhibitor | 2.0 | Terminated | ClinicalTrials |
| DECITABINE | Small molecule | myeloproliferative disorder | DNA (cytosine-5)-methyltransferase 1 inhibitor | 3.0 | Unknown status | ClinicalTrials |
| DECITABINE | Small molecule | esophageal squamous cell carcinoma | DNA (cytosine-5)-methyltransferase 1 inhibitor | 2.0 | Not yet recruiting | ClinicalTrials |
| AZACITIDINE | Small molecule | central nervous system cancer | DNA (cytosine-5)-methyltransferase 1 inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
| DECITABINE | Small molecule | myelodysplastic syndrome | DNA (cytosine-5)-methyltransferase 1 inhibitor | 1.0 | Not yet recruiting | ClinicalTrials |
| AZACITIDINE | Small molecule | acute myeloid leukemia | DNA (cytosine-5)-methyltransferase 1 inhibitor | 1.0 | Not yet recruiting | ClinicalTrials |
| AZACITIDINE | Small molecule | acute myeloid leukemia | DNA (cytosine-5)-methyltransferase 1 inhibitor | 3.0 | Not yet recruiting | ClinicalTrials |
| DECITABINE | Small molecule | HIV-1 infection | DNA (cytosine-5)-methyltransferase 1 inhibitor | 1.0 | Not yet recruiting | ClinicalTrials |
| DECITABINE | Small molecule | metastatic prostate cancer | DNA (cytosine-5)-methyltransferase 1 inhibitor | 1.0 | Withdrawn | ClinicalTrials |
| AZACITIDINE | Small molecule | metastatic melanoma | DNA (cytosine-5)-methyltransferase 1 inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
| AZACITIDINE | Small molecule | brain neoplasm | DNA (cytosine-5)-methyltransferase 1 inhibitor | 0.5 | Completed | ClinicalTrials |
| DECITABINE | Small molecule | pancreatic adenocarcinoma | DNA (cytosine-5)-methyltransferase 1 inhibitor | 2.0 | Recruiting | ClinicalTrials |
| DECITABINE | Small molecule | extranodal nasal NK/T cell lymphoma | DNA (cytosine-5)-methyltransferase 1 inhibitor | 2.0 | Recruiting | ClinicalTrials |
| DECITABINE | Small molecule | childhood acute myeloid leukemia | DNA (cytosine-5)-methyltransferase 1 inhibitor | 1.0 | Completed | ClinicalTrials |
| AZACITIDINE | Small molecule | prostate adenocarcinoma | DNA (cytosine-5)-methyltransferase 1 inhibitor | 2.0 | Completed | ClinicalTrials |
| AZACITIDINE | Small molecule | lymphoma | DNA (cytosine-5)-methyltransferase 1 inhibitor | 1.0 | Recruiting | ClinicalTrials |
| DECITABINE | Small molecule | myeloproliferative disorder | DNA (cytosine-5)-methyltransferase 1 inhibitor | 1.0 | Recruiting | ClinicalTrials |
| AZACITIDINE | Small molecule | acute erythroblastic leukemia | DNA (cytosine-5)-methyltransferase 1 inhibitor | 2.0 | Completed | ClinicalTrials |
| AZACITIDINE | Small molecule | Hodgkins lymphoma | DNA (cytosine-5)-methyltransferase 1 inhibitor | 1.0 | Completed | ClinicalTrials |
| DECITABINE | Small molecule | anemia | DNA (cytosine-5)-methyltransferase 1 inhibitor | 4.0 | - | DailyMed |
| AZACITIDINE | Small molecule | acute myeloid leukemia | DNA (cytosine-5)-methyltransferase 1 inhibitor | 2.0 | Terminated | ClinicalTrials |
| DECITABINE | Small molecule | diffuse large B-cell lymphoma | DNA (cytosine-5)-methyltransferase 1 inhibitor | 3.0 | Recruiting | ClinicalTrials |
| AZACITIDINE | Small molecule | metastatic malignant neoplasm | DNA (cytosine-5)-methyltransferase 1 inhibitor | 1.0 | Terminated | ClinicalTrials |
| AZACITIDINE | Small molecule | diffuse large B-cell lymphoma | DNA (cytosine-5)-methyltransferase 1 inhibitor | 3.0 | Terminated | ClinicalTrials |
| DECITABINE | Small molecule | therapy related acute myeloid leukemia and myelodysplastic syndrome | DNA (cytosine-5)-methyltransferase 1 inhibitor | 1.0 | Terminated | ClinicalTrials |
| AZACITIDINE | Small molecule | myelodysplastic syndrome | DNA (cytosine-5)-methyltransferase 1 inhibitor | 2.0 | Recruiting | ClinicalTrials |
| AZACITIDINE | Small molecule | metastatic colorectal cancer | DNA (cytosine-5)-methyltransferase 1 inhibitor | 2.0 | Completed | ClinicalTrials |
| AZACITIDINE | Small molecule | metastatic malignant neoplasm | DNA (cytosine-5)-methyltransferase 1 inhibitor | 1.0 | Completed | ClinicalTrials |
| DECITABINE | Small molecule | myelodysplastic syndrome | DNA (cytosine-5)-methyltransferase 1 inhibitor | 3.0 | Unknown status | ClinicalTrials |
| AZACITIDINE | Small molecule | lymphoma | DNA (cytosine-5)-methyltransferase 1 inhibitor | 3.0 | Active, not recruiting | ClinicalTrials |
| AZACITIDINE | Small molecule | non-small cell lung carcinoma | DNA (cytosine-5)-methyltransferase 1 inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
| AZACITIDINE | Small molecule | leukemia | DNA (cytosine-5)-methyltransferase 1 inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
| AZACITIDINE | Small molecule | myelodysplastic syndrome | DNA (cytosine-5)-methyltransferase 1 inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
| DECITABINE | Small molecule | melanoma | DNA (cytosine-5)-methyltransferase 1 inhibitor | 2.0 | Withdrawn | ClinicalTrials |
| DECITABINE | Small molecule | breast neoplasm | DNA (cytosine-5)-methyltransferase 1 inhibitor | 2.0 | Terminated | ClinicalTrials |
| DECITABINE | Small molecule | childhood acute lymphoblastic leukemia | DNA (cytosine-5)-methyltransferase 1 inhibitor | 1.0 | Terminated | ClinicalTrials |
| AZACITIDINE | Small molecule | acute myeloid leukemia | DNA (cytosine-5)-methyltransferase 1 inhibitor | 2.0 | Not yet recruiting | ClinicalTrials |
| AZACITIDINE | Small molecule | myelodysplastic syndrome | DNA (cytosine-5)-methyltransferase 1 inhibitor | 1.0 | Not yet recruiting | ClinicalTrials |
| DECITABINE | Small molecule | head and neck malignant neoplasia | DNA (cytosine-5)-methyltransferase 1 inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
| AZACITIDINE | Small molecule | ovarian cancer | DNA (cytosine-5)-methyltransferase 1 inhibitor | 1.0 | Withdrawn | ClinicalTrials |
| DECITABINE | Small molecule | unspecified peripheral T-cell lymphoma | DNA (cytosine-5)-methyltransferase 1 inhibitor | 1.0 | Recruiting | ClinicalTrials |
| DECITABINE | Small molecule | breast cancer | DNA (cytosine-5)-methyltransferase 1 inhibitor | 1.0 | Unknown status | ClinicalTrials |
| AZACITIDINE | Small molecule | malignant colon neoplasm | DNA (cytosine-5)-methyltransferase 1 inhibitor | 2.0 | Completed | ClinicalTrials |
| DECITABINE | Small molecule | neoplasm | DNA (cytosine-5)-methyltransferase 1 inhibitor | 1.0 | Terminated | ClinicalTrials |
| AZACITIDINE | Small molecule | prostate cancer | DNA (cytosine-5)-methyltransferase 1 inhibitor | 2.0 | Completed | ClinicalTrials |
| DECITABINE | Small molecule | acute promyelocytic leukemia | DNA (cytosine-5)-methyltransferase 1 inhibitor | 1.0 | Terminated | ClinicalTrials |
| AZACITIDINE | Small molecule | diffuse large B-cell lymphoma | DNA (cytosine-5)-methyltransferase 1 inhibitor | 1.0 | Recruiting | ClinicalTrials |
| AZACITIDINE | Small molecule | chronic myelomonocytic leukemia | DNA (cytosine-5)-methyltransferase 1 inhibitor | 1.0 | Completed | ClinicalTrials |
| AZACITIDINE | Small molecule | beta-thalassemia major | DNA (cytosine-5)-methyltransferase 1 inhibitor | 2.0 | Terminated | ClinicalTrials |
| DECITABINE | Small molecule | childhood acute myeloid leukemia with maturation | DNA (cytosine-5)-methyltransferase 1 inhibitor | 1.0 | Terminated | ClinicalTrials |
| AZACITIDINE | Small molecule | acute myeloid leukemia | DNA (cytosine-5)-methyltransferase 1 inhibitor | 3.0 | Completed | ClinicalTrials |
| AZACITIDINE | Small molecule | Hodgkins lymphoma | DNA (cytosine-5)-methyltransferase 1 inhibitor | 1.0 | Terminated | ClinicalTrials |
| AZACITIDINE | Small molecule | acute myeloid leukemia | DNA (cytosine-5)-methyltransferase 1 inhibitor | 2.0 | Unknown status | ClinicalTrials |
| AZACITIDINE | Small molecule | follicular lymphoma | DNA (cytosine-5)-methyltransferase 1 inhibitor | 1.0 | Recruiting | ClinicalTrials |
| AZACITIDINE | Small molecule | acute monocytic leukemia | DNA (cytosine-5)-methyltransferase 1 inhibitor | 2.0 | Recruiting | ClinicalTrials |
| AZACITIDINE | Small molecule | myelodysplastic syndrome | DNA (cytosine-5)-methyltransferase 1 inhibitor | 1.0 | Withdrawn | ClinicalTrials |
| DECITABINE | Small molecule | medulloblastoma | DNA (cytosine-5)-methyltransferase 1 inhibitor | 1.0 | Terminated | ClinicalTrials |
| AZACITIDINE | Small molecule | acute myeloid leukemia | DNA (cytosine-5)-methyltransferase 1 inhibitor | 2.0 | Withdrawn | ClinicalTrials |
| AZACITIDINE | Small molecule | acute myeloid leukemia | DNA (cytosine-5)-methyltransferase 1 inhibitor | 1.0 | Completed | ClinicalTrials |
| DECITABINE | Small molecule | papillary thyroid carcinoma | DNA (cytosine-5)-methyltransferase 1 inhibitor | 2.0 | Completed | ClinicalTrials |
| AZACITIDINE | Small molecule | multiple myeloma | DNA (cytosine-5)-methyltransferase 1 inhibitor | 1.0 | Terminated | ClinicalTrials |
| DECITABINE | Small molecule | acute myeloid leukemia | DNA (cytosine-5)-methyltransferase 1 inhibitor | 1.0 | Withdrawn | ClinicalTrials |
| DECITABINE | Small molecule | acute myeloid leukemia | DNA (cytosine-5)-methyltransferase 1 inhibitor | 3.0 | Not yet recruiting | ClinicalTrials |
| AZACITIDINE | Small molecule | chronic myelomonocytic leukemia | DNA (cytosine-5)-methyltransferase 1 inhibitor | 2.0 | Completed | ClinicalTrials |
| DECITABINE | Small molecule | cancer | DNA (cytosine-5)-methyltransferase 1 inhibitor | 3.0 | Recruiting | ClinicalTrials |
| DECITABINE | Small molecule | acute myeloid leukemia | DNA (cytosine-5)-methyltransferase 1 inhibitor | 3.0 | Active, not recruiting | ClinicalTrials |
| DECITABINE | Small molecule | follicular thyroid carcinoma | DNA (cytosine-5)-methyltransferase 1 inhibitor | 2.0 | Completed | ClinicalTrials |
| DECITABINE | Small molecule | acute myeloid leukemia | DNA (cytosine-5)-methyltransferase 1 inhibitor | 1.0 | Completed | ClinicalTrials |
| DECITABINE | Small molecule | lymphoma | DNA (cytosine-5)-methyltransferase 1 inhibitor | 1.0 | Unknown status | ClinicalTrials |
| AZACITIDINE | Small molecule | acute myeloid leukemia | DNA (cytosine-5)-methyltransferase 1 inhibitor | 1.0 | Unknown status | ClinicalTrials |
| DECITABINE | Small molecule | chronic myelogenous leukemia | DNA (cytosine-5)-methyltransferase 1 inhibitor | 2.0 | Completed | ClinicalTrials |
| AZACITIDINE | Small molecule | rectum cancer | DNA (cytosine-5)-methyltransferase 1 inhibitor | 2.0 | Completed | ClinicalTrials |
| DECITABINE | Small molecule | chronic myelomonocytic leukemia | DNA (cytosine-5)-methyltransferase 1 inhibitor | 4.0 | - | DailyMed |
| DECITABINE | Small molecule | diffuse large B-cell lymphoma | DNA (cytosine-5)-methyltransferase 1 inhibitor | 4.0 | Unknown status | ClinicalTrials |
| AZACITIDINE | Small molecule | chronic myelomonocytic leukemia | DNA (cytosine-5)-methyltransferase 1 inhibitor | 3.0 | Active, not recruiting | ClinicalTrials |
| DECITABINE | Small molecule | Thrombocytopenia | DNA (cytosine-5)-methyltransferase 1 inhibitor | 3.0 | Completed | ClinicalTrials |
| AZACITIDINE | Small molecule | blastic plasmacytoid dendritic cell neoplasm | DNA (cytosine-5)-methyltransferase 1 inhibitor | 1.0 | Recruiting | ClinicalTrials |
| DECITABINE | Small molecule | unspecified peripheral T-cell lymphoma | DNA (cytosine-5)-methyltransferase 1 inhibitor | 3.0 | Not yet recruiting | ClinicalTrials |
| AZACITIDINE | Small molecule | myelodysplastic syndrome | DNA (cytosine-5)-methyltransferase 1 inhibitor | 2.0 | Completed | ClinicalTrials |
| DECITABINE | Small molecule | acute myeloid leukemia | DNA (cytosine-5)-methyltransferase 1 inhibitor | 2.0 | Unknown status | ClinicalTrials |
| DECITABINE | Small molecule | COVID-19 | DNA (cytosine-5)-methyltransferase 1 inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
| AZACITIDINE | Small molecule | Hodgkins lymphoma | DNA (cytosine-5)-methyltransferase 1 inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
| DECITABINE | Small molecule | neuroblastoma | DNA (cytosine-5)-methyltransferase 1 inhibitor | 1.0 | Completed | ClinicalTrials |
| DECITABINE | Small molecule | non-small cell lung carcinoma | DNA (cytosine-5)-methyltransferase 1 inhibitor | 1.0 | Recruiting | ClinicalTrials |
| DECITABINE | Small molecule | chronic myelomonocytic leukemia | DNA (cytosine-5)-methyltransferase 1 inhibitor | 1.0 | Recruiting | ClinicalTrials |
| DECITABINE | Small molecule | acute myeloid leukemia | DNA (cytosine-5)-methyltransferase 1 inhibitor | 2.0 | Withdrawn | ClinicalTrials |
| DECITABINE | Small molecule | myeloproliferative disorder | DNA (cytosine-5)-methyltransferase 1 inhibitor | 1.0 | Completed | ClinicalTrials |
| DECITABINE | Small molecule | neoplasm | DNA (cytosine-5)-methyltransferase 1 inhibitor | 4.0 | - | ATC |
| DECITABINE | Small molecule | leukemia | DNA (cytosine-5)-methyltransferase 1 inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
| DECITABINE | Small molecule | melanoma | DNA (cytosine-5)-methyltransferase 1 inhibitor | 1.0 | Terminated | ClinicalTrials |
| DECITABINE | Small molecule | acute myeloid leukemia | DNA (cytosine-5)-methyltransferase 1 inhibitor | 2.0 | Not yet recruiting | ClinicalTrials |
| AZACITIDINE | Small molecule | cutaneous melanoma | DNA (cytosine-5)-methyltransferase 1 inhibitor | 1.0 | Completed | ClinicalTrials |
| DECITABINE | Small molecule | therapy related acute myeloid leukemia and myelodysplastic syndrome | DNA (cytosine-5)-methyltransferase 1 inhibitor | 1.0 | Suspended | ClinicalTrials |
| DECITABINE | Small molecule | digestive system neoplasm | DNA (cytosine-5)-methyltransferase 1 inhibitor | 1.0 | Not yet recruiting | ClinicalTrials |
| AZACITIDINE | Small molecule | hematopoietic and lymphoid cell neoplasm | DNA (cytosine-5)-methyltransferase 1 inhibitor | 1.0 | Completed | ClinicalTrials |
| AZACITIDINE | Small molecule | acute myeloid leukemia | DNA (cytosine-5)-methyltransferase 1 inhibitor | 4.0 | Active, not recruiting | ClinicalTrials |
| DECITABINE | Small molecule | myelodysplastic syndrome | DNA (cytosine-5)-methyltransferase 1 inhibitor | 1.0 | Recruiting | ClinicalTrials |
| DECITABINE | Small molecule | myelodysplastic syndrome | DNA (cytosine-5)-methyltransferase 1 inhibitor | 1.0 | Unknown status | ClinicalTrials |
| DECITABINE | Small molecule | cancer | DNA (cytosine-5)-methyltransferase 1 inhibitor | 1.0 | Terminated | ClinicalTrials |
| DECITABINE | Small molecule | myelodysplastic syndrome | DNA (cytosine-5)-methyltransferase 1 inhibitor | 1.0 | Completed | ClinicalTrials |
| DECITABINE | Small molecule | melanoma | DNA (cytosine-5)-methyltransferase 1 inhibitor | 1.0 | Recruiting | ClinicalTrials |
| DECITABINE | Small molecule | melanoma | DNA (cytosine-5)-methyltransferase 1 inhibitor | 1.0 | Completed | ClinicalTrials |
| DECITABINE | Small molecule | head and neck malignant neoplasia | DNA (cytosine-5)-methyltransferase 1 inhibitor | 1.0 | Terminated | ClinicalTrials |
| AZACITIDINE | Small molecule | acute lymphoblastic leukemia | DNA (cytosine-5)-methyltransferase 1 inhibitor | 1.0 | Completed | ClinicalTrials |
| AZACITIDINE | Small molecule | non-Hodgkins lymphoma | DNA (cytosine-5)-methyltransferase 1 inhibitor | 1.0 | Completed | ClinicalTrials |
| DECITABINE | Small molecule | sickle cell anemia | DNA (cytosine-5)-methyltransferase 1 inhibitor | 2.0 | Recruiting | ClinicalTrials |
| AZACITIDINE | Small molecule | chronic lymphocytic leukemia | DNA (cytosine-5)-methyltransferase 1 inhibitor | 2.0 | Terminated | ClinicalTrials |
| DECITABINE | Small molecule | Burkitts lymphoma | DNA (cytosine-5)-methyltransferase 1 inhibitor | 1.0 | Completed | ClinicalTrials |
| DECITABINE | Small molecule | Cutaneous T-cell lymphoma | DNA (cytosine-5)-methyltransferase 1 inhibitor | 1.0 | Recruiting | ClinicalTrials |
| AZACITIDINE | Small molecule | acute kidney failure | DNA (cytosine-5)-methyltransferase 1 inhibitor | 1.0 | Not yet recruiting | ClinicalTrials |
| AZACITIDINE | Small molecule | cancer | DNA (cytosine-5)-methyltransferase 1 inhibitor | 1.0 | Completed | ClinicalTrials |
| DECITABINE | Small molecule | acute myeloid leukemia | DNA (cytosine-5)-methyltransferase 1 inhibitor | 3.0 | Recruiting | ClinicalTrials |
| DECITABINE | Small molecule | therapy related acute myeloid leukemia and myelodysplastic syndrome | DNA (cytosine-5)-methyltransferase 1 inhibitor | 2.0 | Recruiting | ClinicalTrials |
| AZACITIDINE | Small molecule | angioimmunoblastic T-cell lymphoma | DNA (cytosine-5)-methyltransferase 1 inhibitor | 3.0 | Active, not recruiting | ClinicalTrials |
| AZACITIDINE | Small molecule | lymphoma | DNA (cytosine-5)-methyltransferase 1 inhibitor | 2.0 | Not yet recruiting | ClinicalTrials |
| DECITABINE | Small molecule | neoplasm | DNA (cytosine-5)-methyltransferase 1 inhibitor | 1.0 | Recruiting | ClinicalTrials |
| AZACITIDINE | Small molecule | multiple myeloma | DNA (cytosine-5)-methyltransferase 1 inhibitor | 2.0 | Recruiting | ClinicalTrials |
| DECITABINE | Small molecule | non-Hodgkins lymphoma | DNA (cytosine-5)-methyltransferase 1 inhibitor | 1.0 | Unknown status | ClinicalTrials |
| DECITABINE | Small molecule | primary central chondrosarcoma | DNA (cytosine-5)-methyltransferase 1 inhibitor | 2.0 | Suspended | ClinicalTrials |
| AZACITIDINE | Small molecule | ependymoma | DNA (cytosine-5)-methyltransferase 1 inhibitor | 1.0 | Recruiting | ClinicalTrials |
| AZACITIDINE | Small molecule | myelodysplastic syndrome | DNA (cytosine-5)-methyltransferase 1 inhibitor | 1.0 | Terminated | ClinicalTrials |
| AZACITIDINE | Small molecule | leukemia | DNA (cytosine-5)-methyltransferase 1 inhibitor | 2.0 | Terminated | ClinicalTrials |
| AZACITIDINE | Small molecule | nasopharyngeal neoplasm | DNA (cytosine-5)-methyltransferase 1 inhibitor | 2.0 | Completed | ClinicalTrials |
| AZACITIDINE | Small molecule | hematopoietic and lymphoid cell neoplasm | DNA (cytosine-5)-methyltransferase 1 inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
| AZACITIDINE | Small molecule | renal cell carcinoma | DNA (cytosine-5)-methyltransferase 1 inhibitor | 1.0 | Terminated | ClinicalTrials |
| AZACITIDINE | Small molecule | head and neck malignant neoplasia | DNA (cytosine-5)-methyltransferase 1 inhibitor | 1.0 | Completed | ClinicalTrials |
| AZACITIDINE | Small molecule | tuberculosis | DNA (cytosine-5)-methyltransferase 1 inhibitor | 1.0 | Not yet recruiting | ClinicalTrials |
| AZACITIDINE | Small molecule | lymphoma | DNA (cytosine-5)-methyltransferase 1 inhibitor | 3.0 | Not yet recruiting | ClinicalTrials |
| AZACITIDINE | Small molecule | neoplasm | DNA (cytosine-5)-methyltransferase 1 inhibitor | 4.0 | - | ATC |
| DECITABINE | Small molecule | acute myeloid leukemia | DNA (cytosine-5)-methyltransferase 1 inhibitor | 2.0 | Completed | ClinicalTrials |
| DECITABINE | Small molecule | acute myeloid leukemia | DNA (cytosine-5)-methyltransferase 1 inhibitor | 4.0 | Unknown status | ClinicalTrials |
| AZACITIDINE | Small molecule | neoplasm | DNA (cytosine-5)-methyltransferase 1 inhibitor | 1.0 | Completed | ClinicalTrials |
| AZACITIDINE | Small molecule | therapy related acute myeloid leukemia and myelodysplastic syndrome | DNA (cytosine-5)-methyltransferase 1 inhibitor | 1.0 | Recruiting | ClinicalTrials |
| DECITABINE | Small molecule | sickle cell anemia | DNA (cytosine-5)-methyltransferase 1 inhibitor | 1.0 | Completed | ClinicalTrials |
| AZACITIDINE | Small molecule | leukemia | DNA (cytosine-5)-methyltransferase 1 inhibitor | 3.0 | Active, not recruiting | ClinicalTrials |
| DECITABINE | Small molecule | myelodysplastic syndrome | DNA (cytosine-5)-methyltransferase 1 inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
| AZACITIDINE | Small molecule | pancreatic carcinoma | DNA (cytosine-5)-methyltransferase 1 inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
| DECITABINE | Small molecule | peritoneum cancer | DNA (cytosine-5)-methyltransferase 1 inhibitor | 2.0 | Terminated | ClinicalTrials |
| AZACITIDINE | Small molecule | cancer | DNA (cytosine-5)-methyltransferase 1 inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
| DECITABINE | Small molecule | diffuse large B-cell lymphoma | DNA (cytosine-5)-methyltransferase 1 inhibitor | 1.0 | Completed | ClinicalTrials |
| DECITABINE | Small molecule | ovarian cancer | DNA (cytosine-5)-methyltransferase 1 inhibitor | 2.0 | Terminated | ClinicalTrials |
| AZACITIDINE | Small molecule | ovarian cancer | DNA (cytosine-5)-methyltransferase 1 inhibitor | 2.0 | Terminated | ClinicalTrials |
| AZACITIDINE | Small molecule | lymphoid neoplasm | DNA (cytosine-5)-methyltransferase 1 inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
| DECITABINE | Small molecule | cancer | DNA (cytosine-5)-methyltransferase 1 inhibitor | 1.0 | Recruiting | ClinicalTrials |
| DECITABINE | Small molecule | myelodysplastic syndrome | DNA (cytosine-5)-methyltransferase 1 inhibitor | 4.0 | Terminated | ClinicalTrials |
| AZACITIDINE | Small molecule | myelodysplastic syndrome | DNA (cytosine-5)-methyltransferase 1 inhibitor | 2.0 | Withdrawn | ClinicalTrials |
| DECITABINE | Small molecule | prostate carcinoma | DNA (cytosine-5)-methyltransferase 1 inhibitor | 1.0 | Recruiting | ClinicalTrials |
| DECITABINE | Small molecule | metastatic melanoma | DNA (cytosine-5)-methyltransferase 1 inhibitor | 1.0 | Terminated | ClinicalTrials |
| AZACITIDINE | Small molecule | myelodysplastic syndrome | DNA (cytosine-5)-methyltransferase 1 inhibitor | 4.0 | Completed | ClinicalTrials |
| DECITABINE | Small molecule | multiple myeloma | DNA (cytosine-5)-methyltransferase 1 inhibitor | 1.0 | Completed | ClinicalTrials |
| AZACITIDINE | Small molecule | myelodysplastic syndrome | DNA (cytosine-5)-methyltransferase 1 inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
| AZACITIDINE | Small molecule | non-Hodgkins lymphoma | DNA (cytosine-5)-methyltransferase 1 inhibitor | 1.0 | Recruiting | ClinicalTrials |
| AZACITIDINE | Small molecule | male breast carcinoma | DNA (cytosine-5)-methyltransferase 1 inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
| AZACITIDINE | Small molecule | myelodysplastic syndrome | DNA (cytosine-5)-methyltransferase 1 inhibitor | 2.0 | Unknown status | ClinicalTrials |
| AZACITIDINE | Small molecule | unspecified peripheral T-cell lymphoma | DNA (cytosine-5)-methyltransferase 1 inhibitor | 1.0 | Recruiting | ClinicalTrials |
| AZACITIDINE | Small molecule | acute myeloid leukemia | DNA (cytosine-5)-methyltransferase 1 inhibitor | 3.0 | Terminated | ClinicalTrials |
| DECITABINE | Small molecule | pediatric lymphoma | DNA (cytosine-5)-methyltransferase 1 inhibitor | 0.5 | Active, not recruiting | ClinicalTrials |
| AZACITIDINE | Small molecule | Thrombocytopenia | DNA (cytosine-5)-methyltransferase 1 inhibitor | 3.0 | Terminated | ClinicalTrials |
| DECITABINE | Small molecule | adult lymphoma | DNA (cytosine-5)-methyltransferase 1 inhibitor | 0.5 | Active, not recruiting | ClinicalTrials |
| DECITABINE | Small molecule | non-small cell lung carcinoma | DNA (cytosine-5)-methyltransferase 1 inhibitor | 1.0 | Completed | ClinicalTrials |
| DECITABINE | Small molecule | Hodgkins lymphoma | DNA (cytosine-5)-methyltransferase 1 inhibitor | 2.0 | Recruiting | ClinicalTrials |
| DECITABINE | Small molecule | myelodysplastic syndrome | DNA (cytosine-5)-methyltransferase 1 inhibitor | 3.0 | Completed | ClinicalTrials |
| AZACITIDINE | Small molecule | acute myeloid leukemia | DNA (cytosine-5)-methyltransferase 1 inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
| AZACITIDINE | Small molecule | Thrombocytopenia | DNA (cytosine-5)-methyltransferase 1 inhibitor | 4.0 | - | DailyMed |
| AZACITIDINE | Small molecule | follicular lymphoma | DNA (cytosine-5)-methyltransferase 1 inhibitor | 2.0 | Terminated | ClinicalTrials |
| AZACITIDINE | Small molecule | hematopoietic and lymphoid cell neoplasm | DNA (cytosine-5)-methyltransferase 1 inhibitor | 1.0 | Terminated | ClinicalTrials |
| DECITABINE | Small molecule | acute myeloid leukemia | DNA (cytosine-5)-methyltransferase 1 inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
| DECITABINE | Small molecule | chronic myelomonocytic leukemia | DNA (cytosine-5)-methyltransferase 1 inhibitor | 3.0 | Active, not recruiting | ClinicalTrials |
| DECITABINE | Small molecule | acute myeloid leukemia | DNA (cytosine-5)-methyltransferase 1 inhibitor | 1.0 | Recruiting | ClinicalTrials |
| AZACITIDINE | Small molecule | acute lymphoblastic leukemia | DNA (cytosine-5)-methyltransferase 1 inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
| AZACITIDINE | Small molecule | pancreatic carcinoma | DNA (cytosine-5)-methyltransferase 1 inhibitor | 2.0 | Completed | ClinicalTrials |
| AZACITIDINE | Small molecule | acute myeloid leukemia | DNA (cytosine-5)-methyltransferase 1 inhibitor | 3.0 | Active, not recruiting | ClinicalTrials |
| DECITABINE | Small molecule | acute myeloid leukemia | DNA (cytosine-5)-methyltransferase 1 inhibitor | 3.0 | Completed | ClinicalTrials |
| DECITABINE | Small molecule | Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive | DNA (cytosine-5)-methyltransferase 1 inhibitor | 2.0 | Recruiting | ClinicalTrials |
| AZACITIDINE | Small molecule | myeloid neoplasm | DNA (cytosine-5)-methyltransferase 1 inhibitor | 2.0 | Recruiting | ClinicalTrials |
| DECITABINE | Small molecule | colorectal carcinoma | DNA (cytosine-5)-methyltransferase 1 inhibitor | 1.0 | Completed | ClinicalTrials |
| AZACITIDINE | Small molecule | acute myeloid leukemia | DNA (cytosine-5)-methyltransferase 1 inhibitor | 1.0 | Withdrawn | ClinicalTrials |
| DECITABINE | Small molecule | childhood acute myeloid leukemia | DNA (cytosine-5)-methyltransferase 1 inhibitor | 1.0 | Terminated | ClinicalTrials |
| AZACITIDINE | Small molecule | myelodysplastic syndrome | DNA (cytosine-5)-methyltransferase 1 inhibitor | 4.0 | - | DailyMed |
| AZACITIDINE | Small molecule | osteosarcoma | DNA (cytosine-5)-methyltransferase 1 inhibitor | 1.0 | Recruiting | ClinicalTrials |
| AZACITIDINE | Small molecule | chronic myelomonocytic leukemia | DNA (cytosine-5)-methyltransferase 1 inhibitor | 4.0 | - | DailyMed |
| DECITABINE | Small molecule | diffuse large B-cell lymphoma | DNA (cytosine-5)-methyltransferase 1 inhibitor | 1.0 | Unknown status | ClinicalTrials |
| AZACITIDINE | Small molecule | non-small cell lung carcinoma | DNA (cytosine-5)-methyltransferase 1 inhibitor | 2.0 | Completed | ClinicalTrials |
| AZACITIDINE | Small molecule | refractory anemia with excess blasts | DNA (cytosine-5)-methyltransferase 1 inhibitor | 4.0 | - | DailyMed |
| AZACITIDINE | Small molecule | diffuse large B-cell lymphoma | DNA (cytosine-5)-methyltransferase 1 inhibitor | 1.0 | Completed | ClinicalTrials |
| DECITABINE | Small molecule | myelodysplastic syndrome | DNA (cytosine-5)-methyltransferase 1 inhibitor | 3.0 | Active, not recruiting | ClinicalTrials |
| AZACITIDINE | Small molecule | acute myeloid leukemia | DNA (cytosine-5)-methyltransferase 1 inhibitor | 3.0 | Withdrawn | ClinicalTrials |
| DECITABINE | Small molecule | acute myeloid leukemia | DNA (cytosine-5)-methyltransferase 1 inhibitor | 3.0 | Terminated | ClinicalTrials |
| DECITABINE | Small molecule | leukemia | DNA (cytosine-5)-methyltransferase 1 inhibitor | 3.0 | Recruiting | ClinicalTrials |
| AZACITIDINE | Small molecule | chronic myelomonocytic leukemia | DNA (cytosine-5)-methyltransferase 1 inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
| AZACITIDINE | Small molecule | non-Hodgkins lymphoma | DNA (cytosine-5)-methyltransferase 1 inhibitor | 1.0 | Terminated | ClinicalTrials |
| AZACITIDINE | Small molecule | esophageal cancer | DNA (cytosine-5)-methyltransferase 1 inhibitor | 1.0 | Completed | ClinicalTrials |
| DECITABINE | Small molecule | myelodysplastic syndrome | DNA (cytosine-5)-methyltransferase 1 inhibitor | 2.0 | Terminated | ClinicalTrials |
| DECITABINE | Small molecule | leukemia | DNA (cytosine-5)-methyltransferase 1 inhibitor | 1.0 | Recruiting | ClinicalTrials |
| DECITABINE | Small molecule | myelodysplastic syndrome | DNA (cytosine-5)-methyltransferase 1 inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
| DECITABINE | Small molecule | cutaneous melanoma | DNA (cytosine-5)-methyltransferase 1 inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
| AZACITIDINE | Small molecule | myeloid neoplasm | DNA (cytosine-5)-methyltransferase 1 inhibitor | 1.0 | Completed | ClinicalTrials |
| DECITABINE | Small molecule | fallopian tube cancer | DNA (cytosine-5)-methyltransferase 1 inhibitor | 2.0 | Terminated | ClinicalTrials |
| AZACITIDINE | Small molecule | myelodysplastic/myeloproliferative disease | DNA (cytosine-5)-methyltransferase 1 inhibitor | 1.0 | Completed | ClinicalTrials |
| DECITABINE | Small molecule | myelodysplastic syndrome | DNA (cytosine-5)-methyltransferase 1 inhibitor | 2.0 | Withdrawn | ClinicalTrials |
| AZACITIDINE | Small molecule | myelodysplastic syndrome | DNA (cytosine-5)-methyltransferase 1 inhibitor | 2.0 | Not yet recruiting | ClinicalTrials |
| DECITABINE | Small molecule | T-lymphoblastic lymphoma | DNA (cytosine-5)-methyltransferase 1 inhibitor | 4.0 | Unknown status | ClinicalTrials |
| AZACITIDINE | Small molecule | acute myeloid leukemia | DNA (cytosine-5)-methyltransferase 1 inhibitor | 2.0 | Recruiting | ClinicalTrials |
| DECITABINE | Small molecule | leukemia | DNA (cytosine-5)-methyltransferase 1 inhibitor | 3.0 | Unknown status | ClinicalTrials |
| DECITABINE | Small molecule | renal cell carcinoma | DNA (cytosine-5)-methyltransferase 1 inhibitor | 2.0 | Recruiting | ClinicalTrials |
| AZACITIDINE | Small molecule | hematopoietic and lymphoid cell neoplasm | DNA (cytosine-5)-methyltransferase 1 inhibitor | 2.0 | Recruiting | ClinicalTrials |
| AZACITIDINE | Small molecule | colorectal carcinoma | DNA (cytosine-5)-methyltransferase 1 inhibitor | 1.0 | Completed | ClinicalTrials |
| AZACITIDINE | Small molecule | mixed phenotype acute leukemia | DNA (cytosine-5)-methyltransferase 1 inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
| AZACITIDINE | Small molecule | Hodgkins lymphoma | DNA (cytosine-5)-methyltransferase 1 inhibitor | 2.0 | Recruiting | ClinicalTrials |
| AZACITIDINE | Small molecule | adult acute myeloid leukemia | DNA (cytosine-5)-methyltransferase 1 inhibitor | 1.0 | Completed | ClinicalTrials |
| AZACITIDINE | Small molecule | myelodysplastic syndrome | DNA (cytosine-5)-methyltransferase 1 inhibitor | 1.0 | Suspended | ClinicalTrials |
| AZACITIDINE | Small molecule | acute myeloid leukemia | DNA (cytosine-5)-methyltransferase 1 inhibitor | 1.0 | Terminated | ClinicalTrials |
| AZACITIDINE | Small molecule | lymphoma | DNA (cytosine-5)-methyltransferase 1 inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
| AZACITIDINE | Small molecule | acute myeloid leukemia | DNA (cytosine-5)-methyltransferase 1 inhibitor | 3.0 | Recruiting | ClinicalTrials |
| DECITABINE | Small molecule | diffuse large B-cell lymphoma | DNA (cytosine-5)-methyltransferase 1 inhibitor | 2.0 | Not yet recruiting | ClinicalTrials |
| DECITABINE | Small molecule | acute myeloid leukemia | DNA (cytosine-5)-methyltransferase 1 inhibitor | 3.0 | Unknown status | ClinicalTrials |
| AZACITIDINE | Small molecule | myelodysplastic syndrome | DNA (cytosine-5)-methyltransferase 1 inhibitor | 4.0 | Terminated | ClinicalTrials |
| AZACITIDINE | Small molecule | multiple myeloma | DNA (cytosine-5)-methyltransferase 1 inhibitor | 1.0 | Completed | ClinicalTrials |
| DECITABINE | Small molecule | therapy related acute myeloid leukemia and myelodysplastic syndrome | DNA (cytosine-5)-methyltransferase 1 inhibitor | 1.0 | Recruiting | ClinicalTrials |
| DECITABINE | Small molecule | myelodysplastic syndrome | DNA (cytosine-5)-methyltransferase 1 inhibitor | 2.0 | Unknown status | ClinicalTrials |
| DECITABINE | Small molecule | diffuse large B-cell lymphoma | DNA (cytosine-5)-methyltransferase 1 inhibitor | 2.0 | Recruiting | ClinicalTrials |
| DECITABINE | Small molecule | Thalassemia | DNA (cytosine-5)-methyltransferase 1 inhibitor | 2.0 | Completed | ClinicalTrials |
| AZACITIDINE | Small molecule | systemic mastocytosis | DNA (cytosine-5)-methyltransferase 1 inhibitor | 1.0 | Not yet recruiting | ClinicalTrials |
| DECITABINE | Small molecule | leukemia | DNA (cytosine-5)-methyltransferase 1 inhibitor | 1.0 | Terminated | ClinicalTrials |
| AZACITIDINE | Small molecule | leukemia | DNA (cytosine-5)-methyltransferase 1 inhibitor | 1.0 | Terminated | ClinicalTrials |
| AZACITIDINE | Small molecule | chronic myelomonocytic leukemia | DNA (cytosine-5)-methyltransferase 1 inhibitor | 1.0 | Recruiting | ClinicalTrials |
| AZACITIDINE | Small molecule | mature T-cell and NK-cell non-Hodgkin lymphoma | DNA (cytosine-5)-methyltransferase 1 inhibitor | 2.0 | Recruiting | ClinicalTrials |
| AZACITIDINE | Small molecule | myelodysplastic syndrome | DNA (cytosine-5)-methyltransferase 1 inhibitor | 2.0 | Terminated | ClinicalTrials |
| AZACITIDINE | Small molecule | myelodysplastic syndrome | DNA (cytosine-5)-methyltransferase 1 inhibitor | 3.0 | Active, not recruiting | ClinicalTrials |
| AZACITIDINE | Small molecule | multiple myeloma | DNA (cytosine-5)-methyltransferase 1 inhibitor | 1.0 | Recruiting | ClinicalTrials |
| DECITABINE | Small molecule | myelodysplastic syndrome | DNA (cytosine-5)-methyltransferase 1 inhibitor | 0.5 | Recruiting | ClinicalTrials |
| DECITABINE | Small molecule | myelodysplastic syndrome | DNA (cytosine-5)-methyltransferase 1 inhibitor | 1.0 | Suspended | ClinicalTrials |
| AZACITIDINE | Small molecule | chronic myelogenous leukemia | DNA (cytosine-5)-methyltransferase 1 inhibitor | 1.0 | Recruiting | ClinicalTrials |
| DECITABINE | Small molecule | leukemia | DNA (cytosine-5)-methyltransferase 1 inhibitor | 2.0 | Recruiting | ClinicalTrials |
| AZACITIDINE | Small molecule | childhood ependymoma | DNA (cytosine-5)-methyltransferase 1 inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
| DECITABINE | Small molecule | cancer | DNA (cytosine-5)-methyltransferase 1 inhibitor | 1.0 | Unknown status | ClinicalTrials |
| DECITABINE | Small molecule | central nervous system cancer | DNA (cytosine-5)-methyltransferase 1 inhibitor | 1.0 | Terminated | ClinicalTrials |
| AZACITIDINE | Small molecule | leukemia | DNA (cytosine-5)-methyltransferase 1 inhibitor | 1.0 | Completed | ClinicalTrials |
| AZACITIDINE | Small molecule | metastatic colorectal cancer | DNA (cytosine-5)-methyltransferase 1 inhibitor | 1.0 | Withdrawn | ClinicalTrials |
| DECITABINE | Small molecule | ovarian cancer | DNA (cytosine-5)-methyltransferase 1 inhibitor | 2.0 | Recruiting | ClinicalTrials |
| AZACITIDINE | Small molecule | breast neoplasm | DNA (cytosine-5)-methyltransferase 1 inhibitor | 2.0 | Terminated | ClinicalTrials |
| AZACITIDINE | Small molecule | liposarcoma | DNA (cytosine-5)-methyltransferase 1 inhibitor | 1.0 | Completed | ClinicalTrials |
| AZACITIDINE | Small molecule | myeloproliferative disorder | DNA (cytosine-5)-methyltransferase 1 inhibitor | 2.0 | Not yet recruiting | ClinicalTrials |
| AZACITIDINE | Small molecule | myelodysplastic syndrome | DNA (cytosine-5)-methyltransferase 1 inhibitor | 3.0 | Recruiting | ClinicalTrials |
| DECITABINE | Small molecule | mature T-cell and NK-cell non-Hodgkin lymphoma | DNA (cytosine-5)-methyltransferase 1 inhibitor | 1.0 | Recruiting | ClinicalTrials |
| AZACITIDINE | Small molecule | non-small cell lung carcinoma | DNA (cytosine-5)-methyltransferase 1 inhibitor | 1.0 | Completed | ClinicalTrials |
| DECITABINE | Small molecule | therapy related acute myeloid leukemia and myelodysplastic syndrome | DNA (cytosine-5)-methyltransferase 1 inhibitor | 2.0 | Terminated | ClinicalTrials |
| AZACITIDINE | Small molecule | myelodysplastic syndrome | DNA (cytosine-5)-methyltransferase 1 inhibitor | 0.5 | Recruiting | ClinicalTrials |
| AZACITIDINE | Small molecule | anemia | DNA (cytosine-5)-methyltransferase 1 inhibitor | 4.0 | - | DailyMed |
| DECITABINE | Small molecule | acute myeloid leukemia | DNA (cytosine-5)-methyltransferase 1 inhibitor | 1.0 | Unknown status | ClinicalTrials |
| AZACITIDINE | Small molecule | Thrombocytopenia | DNA (cytosine-5)-methyltransferase 1 inhibitor | 2.0 | Not yet recruiting | ClinicalTrials |
| DECITABINE | Small molecule | neoplasm of mature B-cells | DNA (cytosine-5)-methyltransferase 1 inhibitor | 0.5 | Completed | ClinicalTrials |
| AZACITIDINE | Small molecule | head and neck squamous cell carcinoma | DNA (cytosine-5)-methyltransferase 1 inhibitor | 0.5 | Not yet recruiting | ClinicalTrials |
| AZACITIDINE | Small molecule | unspecified peripheral T-cell lymphoma | DNA (cytosine-5)-methyltransferase 1 inhibitor | 2.0 | Recruiting | ClinicalTrials |
| DECITABINE | Small molecule | breast adenocarcinoma | DNA (cytosine-5)-methyltransferase 1 inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
| DECITABINE | Small molecule | chronic myelomonocytic leukemia | DNA (cytosine-5)-methyltransferase 1 inhibitor | 2.0 | Completed | ClinicalTrials |
| AZACITIDINE | Small molecule | myelodysplastic syndrome | DNA (cytosine-5)-methyltransferase 1 inhibitor | 3.0 | Completed | ClinicalTrials |
| DECITABINE | Small molecule | metastatic melanoma | DNA (cytosine-5)-methyltransferase 1 inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
| AZACITIDINE | Small molecule | pancreatic carcinoma | DNA (cytosine-5)-methyltransferase 1 inhibitor | 1.0 | Terminated | ClinicalTrials |
| DECITABINE | Small molecule | adult acute myeloid leukemia | DNA (cytosine-5)-methyltransferase 1 inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
| DECITABINE | Small molecule | graft versus host disease | DNA (cytosine-5)-methyltransferase 1 inhibitor | 3.0 | Not yet recruiting | ClinicalTrials |
| DECITABINE | Small molecule | leukemia | DNA (cytosine-5)-methyltransferase 1 inhibitor | 1.0 | Completed | ClinicalTrials |
| DECITABINE | Small molecule | myelodysplastic syndrome | DNA (cytosine-5)-methyltransferase 1 inhibitor | 1.0 | Terminated | ClinicalTrials |
| AZACITIDINE | Small molecule | myelodysplastic syndrome | DNA (cytosine-5)-methyltransferase 1 inhibitor | 1.0 | Unknown status | ClinicalTrials |
| DECITABINE | Small molecule | acute myeloid leukemia | DNA (cytosine-5)-methyltransferase 1 inhibitor | 4.0 | Active, not recruiting | ClinicalTrials |
| AZACITIDINE | Small molecule | graft versus host disease | DNA (cytosine-5)-methyltransferase 1 inhibitor | 1.0 | Terminated | ClinicalTrials |
| DECITABINE | Small molecule | therapy related acute myeloid leukemia and myelodysplastic syndrome | DNA (cytosine-5)-methyltransferase 1 inhibitor | 1.0 | Completed | ClinicalTrials |
| AZACITIDINE | Small molecule | T-cell large granular lymphocyte leukemia | DNA (cytosine-5)-methyltransferase 1 inhibitor | 1.0 | Recruiting | ClinicalTrials |
| AZACITIDINE | Small molecule | Beta-thalassemia | DNA (cytosine-5)-methyltransferase 1 inhibitor | 2.0 | Completed | ClinicalTrials |
| DECITABINE | Small molecule | chronic myeloproliferative disorder | DNA (cytosine-5)-methyltransferase 1 inhibitor | 1.0 | Completed | ClinicalTrials |
| DECITABINE | Small molecule | autoimmune thrombocytopenic purpura | DNA (cytosine-5)-methyltransferase 1 inhibitor | 3.0 | Not yet recruiting | ClinicalTrials |
| AZACITIDINE | Small molecule | follicular lymphoma | DNA (cytosine-5)-methyltransferase 1 inhibitor | 1.0 | Completed | ClinicalTrials |
| DECITABINE | Small molecule | myelodysplastic syndrome | DNA (cytosine-5)-methyltransferase 1 inhibitor | 4.0 | - | DailyMed |
| AZACITIDINE | Small molecule | cancer | DNA (cytosine-5)-methyltransferase 1 inhibitor | 1.0 | Terminated | ClinicalTrials |
| DECITABINE | Small molecule | breast cancer | DNA (cytosine-5)-methyltransferase 1 inhibitor | 1.0 | Terminated | ClinicalTrials |
| AZACITIDINE | Small molecule | myelofibrosis | DNA (cytosine-5)-methyltransferase 1 inhibitor | 2.0 | Completed | ClinicalTrials |
| DECITABINE | Small molecule | acute myeloid leukemia | DNA (cytosine-5)-methyltransferase 1 inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
| DECITABINE | Small molecule | non-Hodgkins lymphoma | DNA (cytosine-5)-methyltransferase 1 inhibitor | 1.0 | Recruiting | ClinicalTrials |
| AZACITIDINE | Small molecule | lymphoma | DNA (cytosine-5)-methyltransferase 1 inhibitor | 1.0 | Completed | ClinicalTrials |
| DECITABINE | Small molecule | pancreatic adenocarcinoma | DNA (cytosine-5)-methyltransferase 1 inhibitor | 0.5 | Completed | ClinicalTrials |
| DECITABINE | Small molecule | acute myeloid leukemia | DNA (cytosine-5)-methyltransferase 1 inhibitor | 1.0 | Suspended | ClinicalTrials |
| DECITABINE | Small molecule | autoimmune thrombocytopenic purpura | DNA (cytosine-5)-methyltransferase 1 inhibitor | 2.0 | Completed | ClinicalTrials |
| AZACITIDINE | Small molecule | classic Hodgkin lymphoma | DNA (cytosine-5)-methyltransferase 1 inhibitor | 1.0 | Recruiting | ClinicalTrials |
| DECITABINE | Small molecule | leukemia | DNA (cytosine-5)-methyltransferase 1 inhibitor | 2.0 | Completed | ClinicalTrials |